| Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification B Li, J Jiang, YG Assaraf, H Xiao, ZS Chen, C Huang Drug resistance updates 53, 100720, 2020 | 127 | 2020 |
| Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma J Jiang, L Zhang, H Chen, Y Lei, T Zhang, Y Wang, P Jin, J Lan, L Zhou, ... Autophagy 16 (1), 106-122, 2020 | 104 | 2020 |
| Antioxidant therapy in cancer: rationale and progress M Luo, L Zhou, Z Huang, B Li, EC Nice, J Xu, C Huang Antioxidants 11 (6), 1128, 2022 | 69 | 2022 |
| Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications H Ming, B Li, L Zhou, A Goel, C Huang Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188519, 2021 | 65 | 2021 |
| Oral squamous cell carcinomas: state of the field and emerging directions Y Tan, Z Wang, M Xu, B Li, Z Huang, S Qin, EC Nice, J Tang, C Huang International journal of oral science 15 (1), 44, 2023 | 64 | 2023 |
| Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang, C Huang Bone Research 11 (1), 11, 2023 | 50 | 2023 |
| Drug-induced oxidative stress in cancer treatments: Angel or devil? H Jiang, J Zuo, B Li, R Chen, K Luo, X Xiang, S Lu, C Huang, L Liu, ... Redox Biology 63, 102754, 2023 | 47 | 2023 |
| MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling P Jin, J Jiang, N Xie, L Zhou, Z Huang, L Zhang, S Qin, S Fu, L Peng, ... Cell death & disease 10 (8), 615, 2019 | 44 | 2019 |
| Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei, B Zou Cancers 14 (19), 4568, 2022 | 39 | 2022 |
| Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer L Peng, J Jiang, HN Chen, L Zhou, Z Huang, S Qin, P Jin, M Luo, B Li, ... Cell reports 37 (9), 2021 | 29 | 2021 |
| Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis P Jin, J Jiang, L Zhou, Z Huang, S Qin, HN Chen, L Peng, Z Zhang, B Li, ... EMBO Molecular Medicine 14 (12), e16082, 2022 | 20 | 2022 |
| A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer H Ming, B Li, H Tian, L Zhou, J Jiang, T Zhang, L Qiao, P Wu, EC Nice, ... Materials Today Bio 15, 100289, 2022 | 20 | 2022 |
| Nanoengineering a Zeolitic Imidazolate Framework‐8 Capable of Manipulating Energy Metabolism against Cancer Chemo‐Phototherapy Resistance S Lu, H Tian, L Li, B Li, M Yang, L Zhou, H Jiang, Q Li, W Wang, EC Nice, ... Small 18 (48), 2204926, 2022 | 19 | 2022 |
| Redox control of the dormant cancer cell life cycle B Li, Y Huang, H Ming, EC Nice, R Xuan, C Huang Cells 10 (10), 2707, 2021 | 19 | 2021 |
| PHLDB2 mediates cetuximab resistance via interacting with EGFR in latent metastasis of colorectal cancer M Luo, Z Huang, X Yang, Y Chen, J Jiang, L Zhang, L Zhou, S Qin, P Jin, ... Cellular and molecular gastroenterology and hepatology 13 (4), 1223-1242, 2022 | 18 | 2022 |
| Clinical Chemotherapeutic Agent Coordinated Copper‐Based Nanoadjuvants for Efficiently Sensitizing Cancer Chemo‐Immunotherapy by Cuproptosis‐Mediated Mitochondrial Metabolic … H Tian, J Duan, B Li, S Qin, EC Nice, W Zhang, T Lang, H Zhang, ... Advanced Functional Materials 33 (51), 2306584, 2023 | 16 | 2023 |
| Protein degradation: expanding the toolbox to restrain cancer drug resistance H Ming, B Li, J Jiang, S Qin, EC Nice, W He, T Lang, C Huang Journal of hematology & oncology 16 (1), 6, 2023 | 15 | 2023 |
| Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy S Qin, B Li, H Ming, EC Nice, B Zou, C Huang Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (4), 188749, 2022 | 14 | 2022 |
| Modulation of redox homeostasis: A strategy to overcome cancer drug resistance Y Li, X Zhang, Z Wang, B Li, H Zhu Frontiers in Pharmacology 14, 1156538, 2023 | 12 | 2023 |
| Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant J Jiang, HN Chen, P Jin, L Zhou, L Peng, Z Huang, S Qin, B Li, H Ming, ... Signal Transduction and Targeted Therapy 8 (1), 65, 2023 | 12 | 2023 |
